
Aiforia is a medical software company transforming pathology with AI, to enable better care for each patient.
Pathologists face growing case volumes, complex analyses, and a shortage of specialists. Aiforia offers a complete, end-to-end AI-driven clinical workflow, from worklist to case-level reporting. Aiforia’s AI solutions help clinical, pre-clinical, and academic labs analyze large medical images faster, more accurately, and more consistently, especially in cancer diagnostics.

Continuously increasing cancer prevalence is putting strain on pathologists, who need better sample analysis methods to meet the demand. Digital pathology investments leaped forward with remote work needs during Covid-19 pandemic, which also generated significant interest to automating sample analysis digitally.

Aiforia has spent around a decade building image analysis software for medical research use, reaching a global user base among pathologists. With existing recognition and ability to easily create new image analysis models, Aiforia has quickly been adopted to use in clinical pathology (e.g. Mayo Clinic, NHS, Veneto).

Aiforia prioritizes clinical sales to largest cancer diagnostics providers, leveraging their position within pathology research to win new clinical customers. The company also continues to serve current and new larger research-customers to support product development and open doors to new clinical customers.